Hormones and skin immunity in hidradenitis suppurativa
Part of Skin, Women’s health & pregnancy clinical trials.
This study looks at how sex hormones affect the immune system in the skin, comparing healthy people and those with hidradenitis suppurativa (a painful skin condition). It aims to understand why this condition develops and how it might be treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- If you are pregnant, you must be in your third trimester (between 29 and 37 weeks).
- You must be willing to provide small skin samples (biopsies) for analysis.
- You must agree to genetic testing of your samples.
- You must be covered by the French Health System (not Aide Médicale d'État).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain immune cells (called MAIT cells) in the skin of people with hidradenitis suppurativa, a painful skin condition. It will compare samples from people before they start a new biologic treatment, and may help doctors understand how these treatments work.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.
This study collects information from people with hidradenitis suppurativa (a skin condition causing painful lumps) to better understand the condition and improve care worldwide.
This study uses MRI brain scans to see if brain activity differs in people with hidradenitis suppurativa (a painful skin condition) compared to healthy volunteers. It also tracks how treatment affects the brain over 3 months.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
Hear when a new Skin Immunity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.